NO20024502L - 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler - Google Patents

4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler

Info

Publication number
NO20024502L
NO20024502L NO20024502A NO20024502A NO20024502L NO 20024502 L NO20024502 L NO 20024502L NO 20024502 A NO20024502 A NO 20024502A NO 20024502 A NO20024502 A NO 20024502A NO 20024502 L NO20024502 L NO 20024502L
Authority
NO
Norway
Prior art keywords
cinnolinecarboxamides
antivirals
dihydro
oxo
Prior art date
Application number
NO20024502A
Other languages
English (en)
Other versions
NO20024502D0 (no
Inventor
Valerie A Vaillancourt
Scott D Larsen
Sajiv K Nair
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20024502D0 publication Critical patent/NO20024502D0/no
Publication of NO20024502L publication Critical patent/NO20024502L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20024502A 2000-03-21 2002-09-20 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler NO20024502L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19129100P 2000-03-21 2000-03-21
PCT/US2001/005811 WO2001070706A2 (en) 2000-03-21 2001-03-15 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents

Publications (2)

Publication Number Publication Date
NO20024502D0 NO20024502D0 (no) 2002-09-20
NO20024502L true NO20024502L (no) 2002-11-20

Family

ID=22704885

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024502A NO20024502L (no) 2000-03-21 2002-09-20 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler

Country Status (28)

Country Link
US (1) US6624160B2 (no)
EP (1) EP1265873B1 (no)
JP (1) JP2003528087A (no)
KR (1) KR20020081479A (no)
CN (1) CN1406228A (no)
AR (1) AR027978A1 (no)
AT (1) ATE252086T1 (no)
AU (1) AU2001247224A1 (no)
BR (1) BR0109487A (no)
CA (1) CA2400000A1 (no)
CZ (1) CZ20023141A3 (no)
DE (1) DE60100999T2 (no)
DK (1) DK1265873T3 (no)
EA (1) EA200201002A1 (no)
EE (1) EE200200541A (no)
ES (1) ES2208581T3 (no)
HK (1) HK1052694A1 (no)
HU (1) HUP0300326A3 (no)
IL (1) IL151787A0 (no)
MX (1) MXPA02009251A (no)
NO (1) NO20024502L (no)
NZ (1) NZ521524A (no)
PL (1) PL357443A1 (no)
PT (1) PT1265873E (no)
SI (1) SI1265873T1 (no)
SK (1) SK12102002A3 (no)
WO (1) WO2001070706A2 (no)
ZA (1) ZA200207540B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
JP6237779B2 (ja) * 2012-11-03 2017-11-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害薬
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
CA3155287A1 (en) 2019-09-26 2021-04-01 Novartis Ag Antiviral pyrazolopyridinone compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513639D0 (en) 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
GB8702288D0 (en) * 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides
CA2225555A1 (en) 1995-08-02 1997-02-13 Chiroscience Limited Quinolones and their therapeutic use
WO1997004779A1 (en) 1995-08-02 1997-02-13 Chiroscience Limited Quinolones and their therapeutic use
CN1128790C (zh) 1997-12-22 2003-11-26 法玛西雅厄普约翰美国公司 用作抗病毒剂的4-羟基喹啉-3-甲酰胺和酰肼化合物
AU763636C (en) 1998-01-29 2004-05-27 Daiichi Asubio Pharma Co., Ltd. 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity

Also Published As

Publication number Publication date
NZ521524A (en) 2004-04-30
AU2001247224A1 (en) 2001-10-03
WO2001070706A3 (en) 2002-05-10
HUP0300326A3 (en) 2003-09-29
JP2003528087A (ja) 2003-09-24
CN1406228A (zh) 2003-03-26
CA2400000A1 (en) 2001-09-27
NO20024502D0 (no) 2002-09-20
US6624160B2 (en) 2003-09-23
PT1265873E (pt) 2004-03-31
AR027978A1 (es) 2003-04-23
KR20020081479A (ko) 2002-10-26
IL151787A0 (en) 2003-04-10
DK1265873T3 (da) 2004-02-16
SK12102002A3 (sk) 2003-03-04
ZA200207540B (en) 2003-12-19
DE60100999T2 (de) 2004-09-02
CZ20023141A3 (cs) 2003-02-12
WO2001070706A2 (en) 2001-09-27
DE60100999D1 (en) 2003-11-20
EP1265873B1 (en) 2003-10-15
EE200200541A (et) 2004-04-15
ES2208581T3 (es) 2004-06-16
ATE252086T1 (de) 2003-11-15
EP1265873A2 (en) 2002-12-18
PL357443A1 (en) 2004-07-26
HK1052694A1 (zh) 2003-09-26
SI1265873T1 (en) 2004-02-29
US20020045619A1 (en) 2002-04-18
EA200201002A1 (ru) 2003-02-27
HUP0300326A2 (hu) 2003-07-28
MXPA02009251A (es) 2004-04-05
BR0109487A (pt) 2003-06-10

Similar Documents

Publication Publication Date Title
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
ITTO20010940A0 (it) ,,sedia,,
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
NL1017075A1 (nl) Preparaat.
MX242679B (es) Antranilamidas insecticidas.
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
FI20000004A0 (fi) Flavonoidilääke...
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
CH695519A5 (de) Sperrstromthyristor.
NO20024502D0 (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
BR0210635B1 (pt) produto absorvente.
DK1140851T3 (da) 4-Oxo-1,4-dihydro-3-quinolincarboxamider som antivirale midler
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
ES1046656Y (es) Microplanta de transferencia de residuos solidos urbanos.
DK1177185T3 (da) 4,5,6,7-tetrahydroindazolderivater som antitumormidler
NO20000983D0 (no) Turwok, sammenleggbar
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
DE29908346U1 (de) Raumeck-Tisch, 5-beinig
SE0003157D0 (sv) Antivirals II
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ES1048599Y (es) Maquina de herbotisteria vibernetica.
ITMI20010486A1 (it) Macchina i.s.
ES1046848Y (es) Bombona.
ITBG20000010V0 (it) Flacone ultraplast.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application